Point72 Hong Kong LTD Bio Xcel Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $38,079 - $60,879	-3,403 Reduced 90.51%	357 $4,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $33,952 - $81,028	3,760 New	3,760 $50,000
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $72,210 - $125,938	-3,589 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $85,561 - $114,955	3,589 New	3,589 $109,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $15,401 - $20,579	-530 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $20,691 - $34,238	530 New	530 $23,000
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $86,448 - $115,196	-2,036 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $76,227 - $131,586	2,036 New	2,036 $88,000
Q1 2020 May 15, 2020	SELL	$12.26 - $41.14 $18,733 - $62,861	-1,528 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.05 - $14.61 $3,292 - $11,877	813 Added 113.71%	1,528 $22,000
Q3 2019 Nov 14, 2019	BUY	$7.04 - $11.77 $5,033 - $8,415	715 New	715 $5,000
Q4 2018 Feb 14, 2019	SELL	$2.41 - $7.61 $1,079 - $3,409	-448 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$7.02 - $11.26 $40,372 - $64,756	-5,751 Reduced 92.77%	448 $4,000
Q1 2018 May 15, 2018	BUY	$9.83 - $11.03 $60,936 - $68,374	6,199 New	6,199 $63,000

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.